Bayesian Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bayesian Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,900	Closed	-$292K	–	164
2025 Q4	$292K	Sell	12,900 -5,900	-31%	-$128K	0.67%	51
2025 Q3	$379K	Sell	18,800 -92,100	-83%	-$1.54M	0.08%	338
2025 Q2	$1.58M	Buy	+110,900	New	+$1.3M	0.25%	119
2025 Q1	–	Sell	-32,600	Closed	-$395K	–	707
2024 Q4	$395K	Buy	+32,600	New	+$427K	0.05%	422
2024 Q3	–	Sell	-91,000	Closed	-$1.31M	–	777
2024 Q2	$1.31M	Buy	+91,000	New	+$1.45M	0.15%	177
2023 Q4	–	Sell	-62,541	Closed	-$703K	–	826
2023 Q3	$703K	Buy	+62,541	New	+$726K	0.08%	287
2023 Q1	–	Sell	-48,700	Closed	-$595K	–	877
2022 Q4	$595K	Buy	+48,700	New	+$607K	0.09%	303
2022 Q3	–	Sell	-21,600	Closed	-$424K	–	781
2022 Q2	$424K	Buy	+21,600	New	+$511K	0.08%	376
2022 Q1	–	Sell	-28,900	Closed	-$820K	–	806
2021 Q4	$820K	Buy	28,900 +3,778	+15%	+$118K	0.26%	119
2021 Q3	$801K	Buy	+25,122	New	+$843K	0.23%	115
2021 Q2	–	Sell	-35,989	Closed	-$1.06M	–	474
2021 Q1	$1.06M	Buy	+35,989	New	+$1.11M	0.24%	108
2019 Q4	–	Sell	-13,746	Closed	-$366K	–	637
2019 Q3	$366K	Buy	+13,746	New	+$412K	0.07%	326

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Bayesian Capital Management's ELAN Position: Q1 2026 in Review

Bayesian Capital Management sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 12,900 shares — an estimated $292K sold.

Bayesian Capital Management first reported a position in ELAN in Q3 2019 and held it in 12 quarters. The position peaked at $1.58M in Q2 2025. 518 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Bayesian Capital Management reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
Bayesian Capital Management sold 12,900 Elanco Animal Health shares in Q1 2026, an estimated $292K.
Bayesian Capital Management first reported a position in Elanco Animal Health in Q3 2019 and held it in 12 quarters.
Bayesian Capital Management's Elanco Animal Health position peaked at $1.58M in Q2 2025.
518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.